Actinium Pharmaceuticals
ATNM
ATNM
69 hedge funds and large institutions have $10.2M invested in Actinium Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 17 closing their positions.
Holders
69
Holders Change
-3
Holders Change %
-4.17%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
27
Reduced
14
Closed
17
Calls
$91K
Puts
$6K
Net Calls
+$85K
Net Calls Change
-$44K
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$156K |
2 |
2
Morgan Stanley
New York
|
$272K |
3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$155K |
4 |
4
Renaissance Technologies
New York
|
$240K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$112K |